These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinically relevant mouse models of severe spinal muscular atrophy with respiratory distress type 1. Holbrook SE, Hicks AN, Martin PB, Hines TJ, Castro HP, Cox GA. Hum Mol Genet; 2024 Oct 07; 33(20):1800-1814. PubMed ID: 39128026 [Abstract] [Full Text] [Related]
3. Charcot Marie Tooth disease type 2S with late onset diaphragmatic weakness: An atypical case. Kulshrestha R, Forrester N, Antoniadi T, Willis T, Sethuraman SK, Samuels M. Neuromuscul Disord; 2018 Dec 07; 28(12):1016-1021. PubMed ID: 30409445 [Abstract] [Full Text] [Related]
4. A novel IGHMBP2 variant and clinical diversity in Vietnamese SMARD1 and CMT2S patients. Tran VK, Cao MH, Nguyen TTH, Le PT, Tran HA, Vu DC, Nguyen HT, Nguyen MTP, Bui TH, Nguyen TB, Ta TV, Tran TH. Front Pediatr; 2024 Dec 07; 12():1165492. PubMed ID: 38415210 [Abstract] [Full Text] [Related]
5. The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects. Smith CE, Lorson MA, Ricardez Hernandez SM, Al Rawi Z, Mao J, Marquez J, Villalón E, Keilholz AN, Smith CL, Garro-Kacher MO, Morcos T, Davis DJ, Bryda EC, Nichols NL, Lorson CL. Hum Mol Genet; 2022 Apr 22; 31(8):1293-1307. PubMed ID: 34726235 [Abstract] [Full Text] [Related]
6. Exploring the relationship between IGHMBP2 gene mutations and spinal muscular atrophy with respiratory distress type 1 and Charcot-Marie-Tooth disease type 2S: a systematic review. Tian Y, Xing J, Shi Y, Yuan E. Front Neurosci; 2023 Apr 22; 17():1252075. PubMed ID: 38046662 [Abstract] [Full Text] [Related]